86 related articles for article (PubMed ID: 10063972)
1. Evaluation of pGL1-TNF-alpha therapy in combination with radiation.
Li J; Andres ML; Fodor I; Nelson GA; Gridley DS
Oncol Res; 1998; 10(7):379-87. PubMed ID: 10063972
[TBL] [Abstract][Full Text] [Related]
2. Combination of pGL1-TNF-alpha gene and radiation (proton and gamma-ray) therapy against brain tumor.
Gridley DS; Li J; Kajioka EH; Andres ML; Moyers MF; Slater JM
Anticancer Res; 2000; 20(6B):4195-203. PubMed ID: 11205248
[TBL] [Abstract][Full Text] [Related]
3. TNF-alpha gene and proton radiotherapy in an orthotopic brain tumor model.
Gridley DS; Baer JR; Cao JD; Miller GM; Kim DW; Timiryasova TM; Fodor I; Slater JM
Int J Oncol; 2002 Aug; 21(2):251-9. PubMed ID: 12118318
[TBL] [Abstract][Full Text] [Related]
4. A model using radiation and plasmid-mediated tumor necrosis factor-alpha gene therapy for treatment of glioblastomas.
Baher AG; Andres ML; Folz-Holbeck J; Cao JD; Gridley DS
Anticancer Res; 1999; 19(4B):2917-24. PubMed ID: 10652573
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-alpha enhances antitumor effects of radiation against glioma xenografts.
Gridley DS; Archambeau JO; Andres MA; Mao XW; Wright K; Slater JM
Oncol Res; 1997; 9(5):217-27. PubMed ID: 9306429
[TBL] [Abstract][Full Text] [Related]
6. Adenoviral TNF-alpha gene therapy and radiation damage tumor vasculature in a human malignant glioma xenograft.
Staba MJ; Mauceri HJ; Kufe DW; Hallahan DE; Weichselbaum RR
Gene Ther; 1998 Mar; 5(3):293-300. PubMed ID: 9614548
[TBL] [Abstract][Full Text] [Related]
7. Proton radiation and TNF-alpha/Bax gene therapy for orthotopic C6 brain tumor in Wistar rats.
Gridley DS; Miller GM; Luo X; Cao JD; Timiryasova TM; Fodor I; Slater JM
Technol Cancer Res Treat; 2004 Apr; 3(2):217-27. PubMed ID: 15059028
[TBL] [Abstract][Full Text] [Related]
8. Lymphocyte activation with localized pGL1-TNF-alpha gene therapy in a glioma model.
Gridley DS; Li J; Kajioka EH; Dutta-Roy R; Andres ML; Timiryasova TM; Fodor I
Oncology; 2002; 62(1):66-77. PubMed ID: 11810046
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of TNF-alpha/Bax gene therapy and radiation against C6 glioma xenografts.
Gridley DS; Timiryasova TM; Miller GM; Andres ML; Dutta-Roy R; Bayeta EJ; Fodor I
Technol Cancer Res Treat; 2003 Feb; 2(1):41-50. PubMed ID: 12625753
[TBL] [Abstract][Full Text] [Related]
10. Heat-inducible TNF-alpha gene therapy combined with hyperthermia using magnetic nanoparticles as a novel tumor-targeted therapy.
Ito A; Shinkai M; Honda H; Kobayashi T
Cancer Gene Ther; 2001 Sep; 8(9):649-54. PubMed ID: 11593333
[TBL] [Abstract][Full Text] [Related]
11. Combined alpha tumor necrosis factor gene therapy and engineered dendritic cell vaccine in combating well-established tumors.
Liu Y; Saxena A; Zheng C; Carlsen S; Xiang J
J Gene Med; 2004 Aug; 6(8):857-68. PubMed ID: 15293344
[TBL] [Abstract][Full Text] [Related]
12. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
[TBL] [Abstract][Full Text] [Related]
13. Enhanced apoptosis following treatment with TRA-8 anti-human DR5 monoclonal antibody and overexpression of exogenous Bax in human glioma cells.
Kaliberov S; Stackhouse MA; Kaliberova L; Zhou T; Buchsbaum DJ
Gene Ther; 2004 Apr; 11(8):658-67. PubMed ID: 14973547
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor-alpha-based gene therapy enhances radiation cytotoxicity in human prostate cancer.
Chung TD; Mauceri HJ; Hallahan DE; Yu JJ; Chung S; Grdina WL; Yajnik S; Kufe DW; Weichselbaum RR
Cancer Gene Ther; 1998; 5(6):344-9. PubMed ID: 9917088
[TBL] [Abstract][Full Text] [Related]
15. [Anti-tumor activity of human recombinant TNF against human malignant glioma cell lines and combined effect with Hu INF-beta].
Enomoto H; Yoshida J; Kageyama N; Ueda R; Kato T; Ota K
Gan To Kagaku Ryoho; 1986 May; 13(5):1953-61. PubMed ID: 3085596
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of combined vaccinia virus-mediated antitumor gene therapy with p53, IL-2, and IL-12 in a glioma model.
Chen B; Timiryasova TM; Andres ML; Kajioka EH; Dutta-Roy R; Gridley DS; Fodor I
Cancer Gene Ther; 2000 Nov; 7(11):1437-47. PubMed ID: 11129286
[TBL] [Abstract][Full Text] [Related]
17. [Synergistic effect of bromocriptine combining tumor necrosis factor-alpha on reversing multidrug resistance in a nude mouse model of liver neoplasm].
Ding L; Chen XP; Zhang ZW; Wang H; Cao B; Wang ZH; Li CL
Zhonghua Wai Ke Za Zhi; 2005 Oct; 43(19):1248-53. PubMed ID: 16271222
[TBL] [Abstract][Full Text] [Related]
18. Sensitization of tumor necrosis factor alpha-resistant human melanoma by tumor-specific in vivo transfer of the gene encoding endothelial monocyte-activating polypeptide II using recombinant vaccinia virus.
Gnant MF; Berger AC; Huang J; Puhlmann M; Wu PC; Merino MJ; Bartlett DL; Alexander HR; Libutti SK
Cancer Res; 1999 Sep; 59(18):4668-74. PubMed ID: 10493523
[TBL] [Abstract][Full Text] [Related]
19. Intramuscular gene transfer of soluble tumor necrosis factor-alpha receptor 1 activates vascular endothelial growth factor receptor and accelerates angiogenesis in a rat model of hindlimb ischemia.
Sugano M; Tsuchida K; Makino N
Circulation; 2004 Feb; 109(6):797-802. PubMed ID: 14970118
[TBL] [Abstract][Full Text] [Related]
20. Direct stimulation of apoptotic signaling by soluble Apo2l/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells.
Pollack IF; Erff M; Ashkenazi A
Clin Cancer Res; 2001 May; 7(5):1362-9. PubMed ID: 11350907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
